CD4 and COVID-19: The same remarkable study showed that, while the majority of S-reactive CD4+ T cells from COVID-19 patients co-expressed CD38 and HLA-DR, S-reactive CD4+ T cells from healthy donors, proposed to be cross reactive to other HCoVs, only expressed CD38 and HLA-DR at very low frequencies and co-expression was not observed.